Tamoxifen Citrate (Nolvadex) 10540-29-1 - [ Sell Product ]

Place of Origin : Wuhan,China
Post Date : 08-08-2013
Expiry Date : 08-09-2014

Trade Description

Tamoxifen Citrate (Nolvadex) 10540-29-1
Trade Name: NolvadexType: Bulk Powder; Anti- Estrogen; Anti Cancer
CAS NO: 10540-29-1MF: C26H29NO.C6H8O7 MW: 563.65 Tamoxifen Citrate Content: 99% Quality Standard: USP31Apperance: White To Milk White Crystalline PowderPacking: As Your RequireStorage: Shading, Confined Preservation.
*tamoxifen Is An Antagonist Of The Estrogen Receptor In Breast Tissue Via Its Active Metabolite,hydroxytamexifen.in Other Tissue Such As The Endometrium, Tamoxifen Behaves As An Agonist. Hence Tamoxifen Maybe Be Characterized As A Mixed Agonist, Tamoxifen Has Been The Standard Endocrine Therapy For Hormone Receptor-postive Early Breast Cancer In Pre-menopausal Women, Although Aromatase Inhibitors Has Been Proposed.
*

^{Company Inforamtion}